Health economic evaluation of AI-based diagnostics in the UK’s Heart Failure care pathway
Challenge
A global Pharma-led collaboration with the NHS Trusts, ICS, data hubs and the AHSN in North West London wanted to evaluate the health economic benefits and scalability of digital and AI-based solutions screening, diagnosis and remote monitoring of Heart Failure patients.
Our Approach
LI delivered a world-class clinical and health economic evaluation of the current and future Heart Failure pathway in North West London, engaging the various stakeholders for real world data, clinical validation and criteria for scalable adoption. Our multi-factorial models highlighted the value of innovations in reducing backlogs, inefficiencies and risk of unplanned admissions.
Impact
This work demonstrated a clear differential between community and in-patient care costs as well as quality adjusted life years (QALY) that could be saved from early diagnosis. NHS-wide model estimated £100M+ savings. Trust’s clinical and commercial stakeholders as well as Pharma managers are mobilised and championing these innovations within the wider NHS organisations.
“Samir and his team bring speed and fresh energy to projects, and a true joy in solving problems together.“
Senior MedTech Manager, UK
Commercialisation and Route-to-market strategy for cancer diagnostics
Challenge
A Swiss med-tech company wanted to map the competitor and payer landscape; and reimbursement routes across US, Europe and the UK to articulate the Go-To-Market strategy for its award-winning tumour micro-environment diagnostic technology.
Our Approach
LI delivered a rapid analysis of established and emerging competitors through an SEO-type web scan. LI’s market access expertise was leveraged to deliver investor-ready maps of access and reimbursement routes for diagnostics in Oncology. Precedent exemplars were reviewed to hypothesise a robust GTM strategy, which was then summarised and communicated to investors successfully.
Impact
Client received insights and investor materials in record time within limited budget. The GTM strategy linking current evidence to future access and reimbursement within mature markets was well received by investors as well as industrial partners. The client received their series A funding as a result of this timely collaboration.
Value-based price discovery for remote patient monitoring MedTech in stroke
Challenge
A globally leading MedTech giant wanted to validate an optimal price range for their anti-coagulant measuring device for key payer markets considering value-based procurement and care models.
Our Approach
LI delivered a multi-thronged approach of (1) mapping key stakeholders per payer market; (2) -designing an online survey to capture User-Payer value criteria and Willingness To Pay (MaxDiff and Discrete Choice); and (3) linking price corridor and reimbursement scenarios with ROI.
Impact
This project was well received by the client who appreciated the structured and timely approach of engaging Users as well as Payers across key markets on value-based pricing research. This work led the client to communicate a robust bottom-up pricing strategy and revenue forecast to the Global commercial leads and the Board Directors.
